Signal Transduction for Proteinase-Activated Receptor-2-Triggered Prostaglandin E2 Formation in Human Lung Epithelial Cells
- 1 November 2005
- journal article
- Published by Elsevier in The Journal of Pharmacology and Experimental Therapeutics
- Vol. 315 (2) , 576-589
- https://doi.org/10.1124/jpet.105.089490
Abstract
We investigated proteinase-activated receptor-2 (PAR2)-triggered signal transduction pathways causing increased prostaglandin E2 (PGE2) formation in human lung-derived A549 epithelial cells. The PAR2 agonist, SLIGRL-NH2 (Ser-Leu-Ile-Gly-Arg-Leu-amide), evoked immediate cytosolic Ca2+ mobilization and delayed (0.5-3 h) PGE2 formation. The PAR2-triggered PGE2 formation was attenuated by inhibition of the following signal pathway enzymes: cyclooxygenases 1 and 2 (COX-1 and COX-2, respectively), cytosolic Ca2+-dependent phospholipase A2 (cPLA2), the mitogen-activated protein kinases (MAPKs), mitogen-activated protein kinase/extracellular signal-regulated kinase kinase (MEK)-extracellular signal-regulated kinase (ERK) and p38 MAPK, Src family tyrosine kinase, epidermal growth factor (EGF) receptor tyrosine kinase (EGFRK), and protein kinase C (PKC), but not by inhibition of matrix metalloproteinases. SLIGRL-NH2 caused prompt (5 min) and transient ERK phosphorylation, blocked in part by inhibitors of PKC and tyrosine kinases but not by an EGFRK inhibitor. SLIGRL-NH2 also evoked a relatively delayed (15 min) and persistent (30 min) phosphorylation of p38 MAPK, blocked by inhibitors of Src and EGFRK but not by inhibitors of COX-1 or COX-2. SLIGRL-NH2 elicited a Src inhibitor-blocked prompt (5 min) and transient phosphorylation of the EGFRK. SLIGRL-NH2 up-regulated COX-2 protein and/or mRNA levels that were blocked by inhibition of p38 MAPK, EGFRK, Src, and COX-2 but not MEK-ERK. SLIGRL-NH2 also caused COX-1-dependent up-regulation of microsomal PGE synthase-1 (mPGES-1). We conclude that PAR2-triggered PGE2 formation in A549 cells involves a coordinated up-regulation of COX-2 and mPGES-1 involving cPLA2, increased cytosolic Ca2+, PKC, Src, MEK-ERK, p38 MAPK, Src-mediated EGF receptor trans-activation, and also metabolic products of both COX-1 and COX-2.Keywords
This publication has 36 references indexed in Scilit:
- Proteinase-Activated Receptor-2-Mediated Relaxation in Mouse Tracheal and Bronchial Smooth Muscle: Signal Transduction Mechanisms and Distinct Agonist SensitivityThe Journal of Pharmacology and Experimental Therapeutics, 2004
- Protease-activated Receptor 2 in Colon CancerJournal of Biological Chemistry, 2004
- Distinct roles for protease-activated receptors 1 and 2 in vasomotor modulation in rat superior mesenteric arteryCardiovascular Research, 2004
- Activation of proteinase‐activated receptor 1 stimulates epithelial chloride secretion through a unique MAP kinase‐and cyclo‐oxygenase‐dependent pathwayThe FASEB Journal, 2002
- International Union of Pharmacology. XXVIII. Proteinase-Activated ReceptorsPharmacological Reviews, 2002
- PGE2 Stimulates VEGF Expression in Endothelial Cells via ERK2/JNK1 Signaling PathwaysBiochemical and Biophysical Research Communications, 2001
- Pharmacological dissection of vascular effects caused by activation of protease‐activated receptor 1 and 2 in anesthetized ratsThe FASEB Journal, 2001
- Proteinase-activated receptor-2–mediated matrix metalloproteinase-9 release from airway epithelial cellsJournal of Allergy and Clinical Immunology, 2000
- Selective induction of cyclo‐oxygenase‐2 activity in the permanent human endothelial cell line HUV‐EC‐C: biochemical and pharmacological characterizationBritish Journal of Pharmacology, 1997
- The Concerted Regulation of cPLA2, COX2, and Lipocortin 1 Expression by IL-1β in A549 CellsBiochemical and Biophysical Research Communications, 1996